BIVI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BioVie Inc (BIVI) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock shows weak financial performance, no significant positive trading trends, and lacks strong technical or sentiment-based signals to support a buy decision. The lack of growth, combined with ongoing shareholder investigations, makes it unsuitable for the user's investment profile.
The technical indicators are bearish. The MACD is slightly positive but contracting, RSI is neutral at 39.038, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.08 and resistance at 1.256.
Potential shareholder involvement may lead to improved corporate governance and management transparency, which could enhance shareholder value in the long term.
Ongoing investigations into fiduciary breaches by executives create uncertainty. Financial performance is weak, with declining net income (-15.19% YoY) and EPS (-83.08% YoY). The stock also lacks significant trading trends or insider activity.
In Q2 2026, BioVie reported zero revenue growth (0.00% YoY), a net income loss of -6,069,475 (-15.19% YoY), and a significant drop in EPS to -0.77 (-83.08% YoY). Gross margin remains at 0, indicating no profitability.
No recent analyst ratings or price target changes are available for BioVie Inc.
